Antiallergic activity of 2-phenyl-8-azapurin-6-ones. 1975

B J Broughton, and P Chaplen, and P Knowles, and E Lunt, and S M Marshall, and D L Pain, and K R Wooldridge

The synthesis and antiallergic activity in the rat passive cutaneous anaphylactic reaction of a series of 2-phenyl-8-azapurin-6-ones are described. Early in the investigation, a linear free-energy equation was established in which the activity was related to the size and hydrogen bonding capacity of the ortho substituent in the phenyl ring. This relationship was used to provide guidance and limits for subsequent work leading to 2-o-propoxyphenyl-8-azapurin-6-one which is 40 times more potent than disodium cromoglycate. It is suggested that good antiallergic activity in this series is associated with coplanarity of the phenyl group with the azapurin-6-one which would be favored by a high degree of hydrogen bonding.

UI MeSH Term Description Entries
D006967 Hypersensitivity Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. Allergy,Allergic Reaction,Allergic Reactions,Allergies,Hypersensitivities,Reaction, Allergic,Reactions, Allergic
D008297 Male Males
D010323 Passive Cutaneous Anaphylaxis An evanescent cutaneous reaction occurring when antibody is injected into a local area on the skin and antigen is subsequently injected intravenously along with a dye. The dye makes the rapidly occurring capillary dilatation and increased vascular permeability readily visible by leakage into the reaction site. PCA is a sensitive reaction for detecting very small quantities of antibodies and is also a method for studying the mechanisms of immediate hypersensitivity. Anaphylaxis, Passive Cutaneous,PCA,Cutaneous Anaphylaxis, Passive
D011688 Purinones Oxopurines
D004205 Cromolyn Sodium A chromone complex that acts by inhibiting the release of chemical mediators from sensitized MAST CELLS. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack. Disodium Cromoglycate,Sodium Cromoglycate,Aarane,Bicromat Spray,Cromoglicic Acid,Cromoglycate,Cromoglycic Acid,Cromolyn,FPL-670,Intal,Lomudal,Nalcrom,Nasalcrom,Opticrom,Vicrom,Acid, Cromoglicic,Acid, Cromoglycic,Cromoglycate, Disodium,Cromoglycate, Sodium,FPL 670,FPL670
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001372 Aza Compounds Organic chemicals where carbon atoms have been replaced by nitrogen atoms. Compounds, Aza
D012882 Skin Tests Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. Skin Test,Test, Skin,Tests, Skin
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

B J Broughton, and P Chaplen, and P Knowles, and E Lunt, and S M Marshall, and D L Pain, and K R Wooldridge
December 2001, Farmaco (Societa chimica italiana : 1989),
B J Broughton, and P Chaplen, and P Knowles, and E Lunt, and S M Marshall, and D L Pain, and K R Wooldridge
July 2013, Chemical biology & drug design,
B J Broughton, and P Chaplen, and P Knowles, and E Lunt, and S M Marshall, and D L Pain, and K R Wooldridge
October 1983, Journal of medicinal chemistry,
B J Broughton, and P Chaplen, and P Knowles, and E Lunt, and S M Marshall, and D L Pain, and K R Wooldridge
March 2009, Bioorganic & medicinal chemistry,
B J Broughton, and P Chaplen, and P Knowles, and E Lunt, and S M Marshall, and D L Pain, and K R Wooldridge
December 1971, Journal of medicinal chemistry,
B J Broughton, and P Chaplen, and P Knowles, and E Lunt, and S M Marshall, and D L Pain, and K R Wooldridge
February 1980, Journal of medicinal chemistry,
B J Broughton, and P Chaplen, and P Knowles, and E Lunt, and S M Marshall, and D L Pain, and K R Wooldridge
January 2005, Nucleosides, nucleotides & nucleic acids,
B J Broughton, and P Chaplen, and P Knowles, and E Lunt, and S M Marshall, and D L Pain, and K R Wooldridge
February 1995, Farmaco (Societa chimica italiana : 1989),
B J Broughton, and P Chaplen, and P Knowles, and E Lunt, and S M Marshall, and D L Pain, and K R Wooldridge
August 2021, Molecules (Basel, Switzerland),
B J Broughton, and P Chaplen, and P Knowles, and E Lunt, and S M Marshall, and D L Pain, and K R Wooldridge
February 1991, Bollettino chimico farmaceutico,
Copied contents to your clipboard!